Every one of these innovations began as an idea in a lab. Together, we’re helping them become solutions in clinics.
Read our interview with Darren Redmayne, one of the founding members of the Cancer Impact Club
Driving progress for children and young people
Cancer in children and young people is complex and different to cancer in adults. Thanks to philanthropic support, we’re building a dedicated research strategy that aims to not only improve survival, but to ensure young people can thrive after treatment, free from long-term side effects.
Children like Fearne, diagnosed with acute lymphoblastic leukaemia at four years old, show us why this work matters. She’s now taking part in UK arm of the Cancer Research UK-funded ALLTogether-1 trial, which is discovering how treatment can be tailored according to personal risk factors. Fearne finished her treatment last year and her story reminds us of the hope research can bring.
We’re also supporting three global teams through Cancer Grand Challenges, working on solid tumours in children - an area where new, less toxic treatments are urgently needed. Patient advocates are shaping this work alongside researchers, ensuring that every step is grounded in the experiences of families.
Read more about our patient advocate panels
